chloramphenicol has been researched along with Gram-Positive Bacterial Infections in 30 studies
Amphenicol: Chloramphenicol and its derivatives.
Gram-Positive Bacterial Infections: Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the results of treating vancomycin-resistant Enterococcus faecium (VREF) bacteremia with chloramphenicol." | 7.71 | Chloramphenicol treatment for vancomycin-resistant Enterococcus faecium bacteremia. ( Boucher, HW; Kislak, JW; Labombardi, VJ; Moellering, RC; Ricaurte, JC; Turett, GS, 2001) |
| "To evaluate the results of treating vancomycin-resistant Enterococcus faecium (VREF) bacteremia with chloramphenicol." | 3.71 | Chloramphenicol treatment for vancomycin-resistant Enterococcus faecium bacteremia. ( Boucher, HW; Kislak, JW; Labombardi, VJ; Moellering, RC; Ricaurte, JC; Turett, GS, 2001) |
| "The incidence of bacteremia due to vancomycin-resistant Enterococcus (VRE) has increased markedly in recent years." | 3.70 | The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus. ( Bilker, WB; Brennan, PJ; Lautenbach, E; Schuster, MG, 1998) |
| "Chloramphenicol is a broad spectrum antibiotic that was abandoned in developed countries due to its association with fatal aplastic anemia." | 2.50 | Could chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century. ( Čivljak, R; Di Bella, S; Giannella, M; Petrosillo, N, 2014) |
| "Chloramphenicol was restarted and the patient improved slowly over a period of 16 days." | 1.31 | Emergence of resistance of vancomycin-resistant Enterococcus faecium in a thermal injury patient treated with quinupristin-dalfopristin and cultured epithelial autografts for wound closure. ( Ackerman, BH; Cawley, MJ; Guilday, RJ; Haith, LR; Patton, ML; Reilly, KJ; Rose, CM, 2002) |
| "Using a checkerboard assay, ampicillin, vancomycin, and RP 59500, each in combination with chloramphenicol, were tested for synergy against 23 isolates of vancomycin-resistant enterococci." | 1.30 | In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci. ( Messick, CR; Pendland, SL, 1997) |
| "Chloramphenicol appears to be a useful and well-tolerated agent for the treatment of serious vancomycin-resistant enterococcal infections." | 1.29 | Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. ( Brennan, PJ; Edelstein, PH; Norris, AH; Reilly, JP; Schuster, MG, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (43.33) | 18.2507 |
| 2000's | 6 (20.00) | 29.6817 |
| 2010's | 9 (30.00) | 24.3611 |
| 2020's | 2 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zheng, B | 1 |
| Tomita, H | 1 |
| Inoue, T | 1 |
| Ike, Y | 1 |
| Makawana, JA | 1 |
| Mungra, DC | 1 |
| Patel, MP | 1 |
| Patel, RG | 1 |
| Tumpa, A | 1 |
| Štritof, Z | 1 |
| Pintarić, S | 1 |
| Lagatolla, C | 1 |
| Milic, J | 1 |
| Imperi, F | 1 |
| Cervoni, M | 1 |
| Bressan, R | 1 |
| Luzzati, R | 1 |
| Di Bella, S | 2 |
| Fallah, F | 1 |
| Yousefi, M | 1 |
| Pourmand, MR | 1 |
| Hashemi, A | 1 |
| Nazari Alam, A | 1 |
| Afshar, D | 1 |
| Bender, JK | 1 |
| Fleige, C | 1 |
| Lange, D | 1 |
| Klare, I | 1 |
| Werner, G | 1 |
| Lei, CW | 1 |
| Kang, ZZ | 1 |
| Wu, SK | 1 |
| Chen, YP | 1 |
| Kong, LH | 1 |
| Wang, HN | 1 |
| Čivljak, R | 1 |
| Giannella, M | 1 |
| Petrosillo, N | 1 |
| Wang, Y | 2 |
| Lv, Y | 1 |
| Cai, J | 1 |
| Schwarz, S | 2 |
| Cui, L | 1 |
| Hu, Z | 1 |
| Zhang, R | 1 |
| Li, J | 1 |
| Zhao, Q | 1 |
| He, T | 1 |
| Wang, D | 1 |
| Wang, Z | 1 |
| Shen, Y | 1 |
| Li, Y | 1 |
| Feßler, AT | 1 |
| Wu, C | 2 |
| Yu, H | 1 |
| Deng, X | 1 |
| Xia, X | 1 |
| Shen, J | 2 |
| Tamang, MD | 1 |
| Moon, DC | 1 |
| Kim, SR | 1 |
| Kang, HY | 1 |
| Lee, K | 1 |
| Nam, HM | 1 |
| Jang, GC | 1 |
| Lee, HS | 1 |
| Jung, SC | 1 |
| Lim, SK | 1 |
| Hartmann, C | 1 |
| Peter, C | 1 |
| Hermann, E | 1 |
| Ure, B | 1 |
| Sedlacek, L | 1 |
| Hansen, G | 1 |
| Bohnhorst, B | 1 |
| Liu, Y | 1 |
| Shen, Z | 1 |
| Du, XD | 1 |
| Dai, L | 1 |
| Zhang, W | 1 |
| Zhang, Q | 1 |
| Rose, CM | 1 |
| Reilly, KJ | 1 |
| Haith, LR | 1 |
| Patton, ML | 1 |
| Guilday, RJ | 1 |
| Cawley, MJ | 1 |
| Ackerman, BH | 1 |
| Zarroug, AE | 1 |
| Golkar, L | 1 |
| Eachempati, SR | 1 |
| Barie, PS | 1 |
| Lautenbach, E | 2 |
| Gould, CV | 1 |
| LaRosa, LA | 1 |
| Marr, AM | 1 |
| Nachamkin, I | 1 |
| Bilker, WB | 2 |
| Fishman, NO | 1 |
| Inan, D | 1 |
| Gunseren, F | 1 |
| Colak, D | 1 |
| Saba, R | 1 |
| Kazan, S | 1 |
| Mamikoglu, L | 1 |
| Norris, AH | 1 |
| Reilly, JP | 1 |
| Edelstein, PH | 1 |
| Brennan, PJ | 2 |
| Schuster, MG | 2 |
| Mirdha, BR | 1 |
| Kumar, P | 1 |
| Drago, SD | 1 |
| Pednekar, SJ | 1 |
| Marketkar, S | 1 |
| Pazare, AR | 1 |
| Moulick, NC | 1 |
| Papanicolaou, GA | 1 |
| Meyers, BR | 1 |
| Meyers, J | 1 |
| Mendelson, MH | 1 |
| Lou, W | 1 |
| Emre, S | 1 |
| Sheiner, P | 1 |
| Miller, C | 1 |
| Messick, CR | 1 |
| Pendland, SL | 1 |
| Fluhr, JW | 1 |
| Gloor, M | 1 |
| Dietz, P | 1 |
| Höffler, U | 1 |
| Pérez Mato, S | 1 |
| Robinson, S | 1 |
| Bégué, RE | 1 |
| Schouten, MA | 1 |
| Voss, A | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| Ricaurte, JC | 1 |
| Boucher, HW | 1 |
| Turett, GS | 1 |
| Moellering, RC | 1 |
| Labombardi, VJ | 1 |
| Kislak, JW | 1 |
| Navashin, SM | 1 |
| Navashin, PS | 1 |
| Pivetti-Pezzi, P | 1 |
| Accorinti, M | 1 |
| Sherman, MD | 1 |
| Ostler, HB | 1 |
| Biswell, R | 1 |
| Cevallos, V | 1 |
| Duel, P | 1 |
| Siboni, K | 1 |
| Jensen, TG | 1 |
1 review available for chloramphenicol and Gram-Positive Bacterial Infections
| Article | Year |
|---|---|
Could chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century.
Topics: Acinetobacter baumannii; Anemia, Aplastic; Anti-Bacterial Agents; Chloramphenicol; Colistin; Drug Re | 2014 |
29 other studies available for chloramphenicol and Gram-Positive Bacterial Infections
| Article | Year |
|---|---|
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Bacteriocins; Blotting, Southern; Co | 2009 |
Microwave assisted synthesis and antimicrobial evaluation of new fused pyran derivatives bearing 2-morpholinoquinoline nucleus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Candida albicans; Fungi; Gram-Negative Bacte | 2011 |
Prevalence and antimicrobial susceptibility of Enterococcus spp. from urine of dogs and cats in northwestern Croatia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cat Diseases; Cats; Chloramphenic | 2022 |
Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Disease Models, Animal; Drug Synergism; Enterococcu | 2021 |
Phenotypic and genotypic study of biofilm formation in Enterococci isolated from urinary tract infections.
Topics: Anti-Bacterial Agents; Biofilms; Chloramphenicol; Drug Resistance, Bacterial; Enterococcus; Enteroco | 2017 |
Rapid emergence of highly variable and transferable oxazolidinone and phenicol resistance gene optrA in German Enterococcus spp. clinical isolates.
Topics: Anti-Infective Agents; Chloramphenicol; Conjugation, Genetic; Drug Resistance, Bacterial; Enterococc | 2018 |
Detection of the phenicol-oxazolidinone-tetracycline resistance gene poxtA in Enterococcus faecium and Enterococcus faecalis of food-producing animal origin in China.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; China; Chloramphenicol; Drug Resistance, Multiple | 2019 |
A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Cluster Analysis; Conjugation, Genetic; DNA, Bacter | 2015 |
Detection of novel oxazolidinone and phenicol resistance gene optrA in enterococcal isolates from food animals and animal carcasses.
Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; Cattle; Chickens; Chloramphenicol; Drug | 2017 |
Successful treatment of vancomycin-resistant Enterococcus faecium ventriculitis with combined intravenous and intraventricular chloramphenicol in a newborn.
Topics: Acetamides; Anti-Bacterial Agents; Cerebral Ventricles; Cerebrospinal Fluid; Chloramphenicol; Enceph | 2010 |
First report of the multidrug resistance gene cfr in Enterococcus faecalis of animal origin.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cattle; Cattle Diseases; Chloramphenicol; DNA Tr | 2012 |
Emergence of resistance of vancomycin-resistant Enterococcus faecium in a thermal injury patient treated with quinupristin-dalfopristin and cultured epithelial autografts for wound closure.
Topics: Adult; Burns; Chloramphenicol; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus f | 2002 |
Vancomycin-resistant Enterococcus ventriculo-peritoneal shunt infection cured by monotherapy with chloramphenicol.
Topics: Aged; Anti-Bacterial Agents; Chloramphenicol; Enterococcus faecium; Female; Gram-Positive Bacterial | 2003 |
Emergence of resistance to chloramphenicol among vancomycin-resistant enterococcal (VRE) bloodstream isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Blood; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Ent | 2004 |
First confirmed case of vancomycin-resistant Enterococcus faecium meningitis in Turkey: case report and literature review.
Topics: Adult; Anti-Bacterial Agents; Cerebrospinal Fluid; Chloramphenicol; Cross Infection; Enterococcus fa | 2004 |
Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections.
Topics: Adult; Aged; Aged, 80 and over; Chloramphenicol; Drug Resistance, Microbial; Enterococcus; Female; G | 1995 |
Primary anaerobic bacterial meningitis caused by Propionibacterium acnes.
Topics: Child, Preschool; Chloramphenicol; Female; Gram-Positive Bacterial Infections; Humans; Meningitis, B | 1993 |
Recurrent pyogenic meningitis.
Topics: Adult; Anti-Bacterial Agents; Cerebrospinal Fluid; Chloramphenicol; Female; Gram-Positive Bacteria; | 1995 |
Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality.
Topics: Anti-Bacterial Agents; Case-Control Studies; Chloramphenicol; Cross Infection; DNA, Bacterial; Doxyc | 1996 |
In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Cross Infection; Drug Resistance, Microbial; Dru | 1997 |
The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Chloramphenicol; Drug | 1998 |
In Vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Erythromycin; | 1999 |
Vancomycin-resistant Enterococcus faecium meningitis successfully treated with chloramphenicol.
Topics: Anti-Bacterial Agents; Chloramphenicol; Drug Resistance, Microbial; Enterococcus faecium; Female; Gr | 1999 |
Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group.
Topics: Anti-Bacterial Agents; Carbapenems; Cefpirome; Cephalosporins; Chloramphenicol; Enterococcus faecali | 1999 |
Chloramphenicol treatment for vancomycin-resistant Enterococcus faecium bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Chloramphenicol; Enterococcus fae | 2001 |
[Chloramphenicol (levomycetin) in the current therapy of bacterial infections].
Topics: Adult; Child; Chloramphenicol; Chloramphenicol Resistance; Gram-Negative Bacteria; Gram-Negative Bac | 1992 |
Propionibacterium endophthalmitis.
Topics: Administration, Oral; Cataract Extraction; Chloramphenicol; Endophthalmitis; Eye Infections, Bacteri | 1992 |
Enterococcus faecalis infection in a corneal graft.
Topics: Chloramphenicol; Corneal Ulcer; Drug Therapy, Combination; Enterococcus faecalis; Eye Infections, Ba | 1992 |
Intracranial abscesses in Odense Hospital. Survey of bacteriology, epidemiology, and treatment with antibiotics, 1963-1989.
Topics: Adolescent; Adult; Aged; Ampicillin; Bacteroides Infections; Brain Abscess; Cefotaxime; Child; Child | 1991 |